Status:

COMPLETED

The Mass Balance and Biotransformation Study of [14C] VC005 in Chinese Healthy Adult Male Volunteers

Lead Sponsor:

Jiangsu vcare pharmaceutical technology co., LTD

Conditions:

Atopic Dermatitis

Eligibility:

MALE

18-45 years

Phase:

PHASE1

Brief Summary

This study was designed to evaluate the mass balance and biotransformation after single-dose of \[14C\]VC005 orally in Chinese healthy male volunteers.

Eligibility Criteria

Inclusion

  • A healthy male adult.
  • Age is between 18 and 45, inclusive.
  • Weight ≥ 50 kg and Body mass index is between 19 and 26, inclusive.
  • Voluntarily to provide informed consent form.
  • Willing and able to communicate with investigators and complete the trial according to clinical trial protocol.

Exclusion

  • Any abnormal and clinical significant findings to physical examination, vital signs, laboratory tests (blood routine, blood biochemistry, coagulation function, urine routine, stool routine+occult blood, thyroid function), 12 lead electrocardiogram, chest X-ray (upright position), abdominal ultrasound (liver, gallbladder, pancreas, spleen and kidney), anal directorial rectum examination, and so on.
  • Tested positive for any one of the following: HBsAg/HBeAg, Anti-HCV IgG, HIV-Ag/Ab or treponema pallidum antibody (Syphilis) .
  • Volunteers who have to work in radioactive conditions in long time, participated in radio-labeled drug clinical trial or had significant radioactive exposure within one year before the trial, more than 2 times of chest/abdominal CT, or more than 3 times of different types of X-ray exam.
  • Volunteers are not suitable for this clinical trial, in the opinions of investigators.

Key Trial Info

Start Date :

May 26 2025

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 3 2025

Estimated Enrollment :

6 Patients enrolled

Trial Details

Trial ID

NCT06974292

Start Date

May 26 2025

End Date

June 3 2025

Last Update

July 11 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The First Affiliated Hospital of Suzhou University

Suzhou, Jiangsu, China